THE US Food and Drug
Administration has approved
Picato(R) (ingenol mebutate) gel
(0.015%, 0.05%) as a treatment for
actinic keratoses (AK) on the face,
scalp, trunk and extremities.
The gel is designed to be used as
a once daily field-directed topical
treatment for AK, a potential
precursor to non-melanoma skin
cancer caused by cumulative sun
exposure.
Treatment with Picato(R) gel is
completed over two consecutive
days for AK on the trunk and
extremities and over three
consecutive days on the face and
scalp.The above article was sent to subscribers in Pharmacy Daily's issue from 27 Jan 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Jan 12
PATIENTS who legitimately need compounded Ozempic should still have access to the medication, even if a government ban comes into effect, advises the Consumers Health Forum of Australia (CHF).
QUEENSLAND pharmacists can commence their full scope of practice journey with the newly launched Prescribing Hormonal Contraceptives Course by the Australasian College of Pharmacy.
A SURGE in international and local demand has led to complementary medicines becoming a huge success story for Australia, according to peak body Complementary Medicines Australia.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.